Do you want to read an article? Please log in or register.
Type 1 interferons as a potential treatment against COVID-19
Viral Infections, Non-HIV
Related content
Viral Infections, Non-HIV
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Cell Host Microbe.
Park A, Iwasaki A
doi: 10.1016/j.chom.2020.05.008.
Viral Infections, Non-HIV
Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy
Int J Infect Dis.
Sun M, Xu Y, He H, Zhang L, Wang X, Qiu Q, Sun C, Guo Y, Qiu S, Ma K
doi: 10.1016/j.ijid.2020.06.107.
Viral Infections, Non-HIV
Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization
Clin Infect Dis
Fintzi J, Bonnett T, Sweeney DA, Huprikar NA, Ganesan A, Frank MG, McLellan SLF, Dodd LE, Tebas P, Mehta AK
doi: 10.1093/cid/ciab712
Viral Infections, Non-HIV
Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
Crit Rev Oncol Hematol.
Jafari A, Dadkhahfar S, Perseh S
doi: 10.1016/j.critrevonc.2020.102982.
RECOMMENDED
Viral Infections, Non-HIV
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Immunol
de Prost N, Bastard P, Arrestier R, Fourati S, Mahévas M, Burrel S, Dorgham K, Gorochov G, Tandjaoui-Lambiotte Y, Azzaoui I, Fernandes I, Combes A, Casanova JL, Mekontso-Dessap A, Luyt CE
doi: 10.1007/s10875-021-00994-9
Viral Infections, Non-HIV
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Lancet.
Furtado RHM, Berwanger O, Fonseca HA, Corrêa TD, Ferraz LR, Lapa MG, Zampieri FG, Veiga VC, Azevedo LCP, Rosa RG, Lopes RD, Avezum A, Manoel ALO, Piza FMT, Martins PA, Lisboa TC, Pereira AJ, Olivato GB, Dantas VCS, Milan EP, Gebara OCE, Amazonas RB, Oliveira MB, Soares RVP, Moia DDF, Piano LPA, Castilho K, Momesso RGRAP, Schettino GPP, Rizzo LV, Neto AS, Machado FR, Cavalcanti AB, COALITION COVID-19 Brazil II Investigators
doi: 10.1016/S0140-6736(20)31862-6.
Viral Infections, Non-HIV
Unravelling potential severe psychiatric repercussions on healthcare professionals during the COVID-19 crisis
J Affect Disord.
Anmella G, Fico G, Roca A, Gómez M, Vázquez M, Murru A, Pacchiarotti I, Verdolini N, Vieta E
doi: 10.1016/j.jad.2020.05.061.
Viral Infections, Non-HIV
Remdesivir for the Treatment of Covid-19 - Preliminary Report
N Engl J Med.
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC, ACTT-1 Study Group Members.
doi: 10.1056/NEJMoa2007764.
Viral Infections, Non-HIV
Renin-Angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry
Am Heart J
Núñez-Gil IJ, Olier I, Feltes G, Viana-Llamas MC, Maroun-Eid C, Romero R, Fernández-Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, García-Aguado M, Elola J, Castro-Mejía A, Pepe M, Garcia-Prieto JF, Gonzalez A, Ugo F, Cerrato E, Bondia E, Raposeiras S, Mendez JLJ, Espejo C, Masjuan ÁL, Marin F, López-Pais J, Abumayyaleh M, Corbi-Pascual M, Liebetrau C, Ramakrisna H, Estrada V, Macaya C, HOPE COVID-19 investigators (Cols appendix).
doi: 10.1016/j.ahj.2021.04.001